Dr Charlene McShane

Keywords: premalignant; cancer; myeloma; outcomes


Charlene is a Cancer Research UK Population Science Research Fellow within the Centre for Public Health, Queen’s University Belfast.  Since graduating with a PhD in cancer epidemiology in July 2015 (Queen’s University Belfast), Charlene’s research continues to focus on haematological malignancies/disorders which were the focus of her PhD thesis. In March 2015, Charlene began her Cancer Research UK fellowship which aims to establish a population-based register of monoclonal gammopathy of undetermined significance (MGUS), the premalignant precursor to multiple myeloma, within the Northern Ireland Cancer Registry.  Once established, the MGUS register will be used to investigate important patient outcomes including survival and progression to malignancy.  Charlene is also interested in the impact of receiving a premalignant diagnosis and is a member of the AiMS (Assessing the impact of MGUS) study team within the Centre for Public Health.